retatrutide type 2 diabetes phase 2 trial 2024 Test results on a popular unapproved peptide have revealed a concentration double that listed on the label, prompting warnings from health professionals about "enormous" overdose risks. By national health equity reporters Caitlyn Advancements in Clinical Research and

Zoloft can potentially cause weight gain (or even weight loss), but not everyone who takes sertraline will experience this side effect.

202125GLP-1

Because if protein, supplements, coaching, strength training, CGMs, or nutrition programs can improve GLP-1 outcomes, reduce side effects, or help people maintain results after discontinuation That is not just wellness. That is evidence worth generating

As noted by Novo Nordisks CEO, it is both surprising but also positive for the commercial development of the obesity market that large populations in both the US and Europe have shown willingness to pay for private prescriptions of Wegovy and other agents out of pocket

Get affordable online weight loss management with experienced doctors

Lilly will be launching small molecule orforglipron in late 2026 following an FDA PDUFA date in April, having built over $1bn in inventory as it anticipates high demand